CITIGROUP INC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$6,000
+500.0%
24,402
+1120.1%
0.00%
Q1 2022$1,000
-90.9%
2,000
-69.9%
0.00%
Q1 2021$11,000
-42.1%
6,642
-56.0%
0.00%
Q4 2020$19,000
+280.0%
15,085
+292.3%
0.00%
Q3 2020$5,000
-61.5%
3,845
-63.4%
0.00%
Q2 2020$13,000
-51.9%
10,509
-53.8%
0.00%
Q1 2020$27,000
-18.2%
22,749
+44.7%
0.00%
Q4 2019$33,000
+230.0%
15,724
+235.1%
0.00%
Q3 2019$10,000
-82.5%
4,692
-79.1%
0.00%
Q2 2019$57,000
-85.5%
22,487
-80.1%
0.00%
Q1 2019$394,000
+994.4%
113,056
+896.3%
0.00%
Q1 2017$36,000
-70.5%
11,348
-75.8%
0.00%
Q4 2016$122,000
+121.8%
46,852
+231.4%
0.00%
Q3 2016$55,000
+37.5%
14,138
-4.5%
0.00%
Q2 2016$40,000
+14.3%
14,801
+31.8%
0.00%
Q1 2016$35,000
-30.0%
11,234
-13.8%
0.00%
Q4 2015$50,000
-15.3%
13,034
-32.9%
0.00%
Q3 2015$59,000
-28.9%
19,435
-0.9%
0.00%
Q2 2015$83,000
+176.7%
19,613
+154.5%
0.00%
Q1 2015$30,000
-68.8%
7,707
-46.2%
0.00%
Q4 2014$96,000
+255.6%
14,330
+196.8%
0.00%
Q3 2014$27,000
+237.5%
4,828
+542.9%
0.00%
Q2 2014$8,000
-91.8%
751
-90.8%
0.00%
Q1 2014$98,000
-39.5%
8,145
-43.2%
0.00%
Q4 2013$162,00014,335
+46141.9%
0.00%
Q3 2013$031
+14.8%
0.00%
Q2 2013$0270.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 3,731,342$8,022,0000.40%
WealthTrust Axiom LLC 210,000$451,0000.17%
Palo Alto Investors LP 1,032,715$2,220,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 144,536$311,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$107,0000.06%
Joel Isaacson & Co., LLC 70,660$152,0000.03%
LMR Partners LLP 148,309$319,0000.02%
LINCOLN CAPITAL CORP 10,000$22,0000.02%
Malaga Cove Capital, LLC 13,150$28,0000.02%
Cornerstone Capital, Inc. 30,000$65,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders